CTEPH is a rare but important consequence of acute pulmonary embolism, highlighting the need for diagnostic and treatment algorithms.
CTEPH incidence after treated PE warrants clinical vigilance; leaves open standardized post-PE surveillance algorithms.
Copyright © Polskie Towarzystwo Kardiologiczne INTRODUCTION The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) requires an objective demonstration of two components of the disease: pulmonary hypertension in haemodynamic studies of the pulmonary circulation (mean pulmonary arterial pressure [MPAP] ≥ 25 mm Hg) and thromboembolic changes in imaging studies. Although the aetiology and pathogenesis of CTEPH has not yet been completely elucidated, the association between a previous diagnosis of acute pulmonary embolism (APE) can be demonstrated in up to about 50% of the cases. CTEPH is, however, a very rare consequence of diagnosed and treated APE. Its incidence is estimated at 0.1–0.5% [1], although, according to Pengo et al. [2], it may be even up to 3.8%.
No takes yet. Share an insight, caveat, or question.
Lewczuk et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: